Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Get Alerts

Biocon Ltd

NSE: BIOCON · BSE: 532523 · Pharmaceuticals & Biotechnology · 57 announcements

Biocon Ltd news stories on ALFA NewsRead the news →
Share price
₹360.00
Market cap
₹58,669 Cr
Revenue (annual)
₹16,927 Cr
Net profit (annual)
₹385.6 Cr
P/E (TTM)
118.5×Sector 47.4×
Promoter holding
44.68%-0.23% QoQ
FII holding
8.14%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Regulatory Approval 6Earnings Call 6Annual General Meeting 6Other Announcement 4Capital Structure Change 4Business Update 4New Order Win 3Management Change 3Fund Raise 3Financial Results 3Results Update 2Merger & Restructuring 2Board Meeting Outcome 2Board Meeting Date 2Acquisition 2Product Launch 1Price Movement Clarification 1Dividend 1Annual Report 1

Time

All time Last 1 weekLast 1 monthLast 2 monthsLast 3 monthsLast 6 monthsLast 1 year

2 announcements with these filters

19:43 IST BSE
Acquisition

Biocon Acquisition Worth ₹5.48 Cr

Biocon invested Rs.5.48 Crore for a 37.77% stake in Ampin C&I Power Twelve, a solar SPV. This supports its renewable energy goals and reduces carbon footprint.

Value
₹5.48 Cr
Read the filing ↗
20:25 IST NSE
Acquisition

Biocon Acquisition Worth ₹330.7 Cr

Biocon will acquire a minority stake in Biocon Biologics for ₹330.73 Crore via share-swap. The deal consolidates BBL as a wholly owned subsidiary by June 2026.

Value
₹330.7 Cr
Execution
30/06/2026
Read the filing ↗